(CRDO) Credo Technology Holding - Overview
Stock: Electrical Cables, Optical DSPs, PHY Chips, SerDes IP, PCIe Retimers
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 88.3% |
| Relative Tail Risk | -6.03% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.77 |
| Alpha | 5.38 |
| Character TTM | |
|---|---|
| Beta | 2.641 |
| Beta Downside | 2.541 |
| Drawdowns 3y | |
|---|---|
| Max DD | 62.04% |
| CAGR/Max DD | 1.33 |
Description: CRDO Credo Technology Holding December 17, 2025
Credo Technology Group Holding Ltd (NASDAQ:CRDO) designs and sells high-speed connectivity solutions-including active electrical HiWire cables, optical PAM4 DSPs, low-power line-card PHYs, and SerDes chiplets/IP-for Ethernet and PCIe markets across the U.S., Taiwan, Mainland China, Hong Kong, and globally. Its product portfolio also covers predictive link-integrity optimization, PCIe retimers, and related support, licensing, and royalty services, targeting hyperscalers, OEMs, ODMs, optical-module makers, enterprise, and high-performance computing (HPC) customers.
Recent filings show Q4 2023 revenue of roughly $12.5 million, an 18 % year-over-year increase driven by rising demand for 400 Gbps Ethernet and PCIe 5.0/6.0 interconnects in AI-focused data centers. The company reported a cash balance of $30 million, giving it runway to fund its next-generation PAM4 and SerDes development. Macro-level, the sector is buoyed by a projected 12 % CAGR in global data-center bandwidth spending through 2028, while supply-chain tightening on advanced silicon nodes adds pricing power for niche high-speed IP licensors.
For a deeper dive into Credo’s financials and valuation multiples, consult ValueRay’s analyst overview.
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income: 212.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.10 > 0.02 and ΔFCF/TA 14.60 > 1.0 |
| NWC/Revenue: 138.6% < 20% (prev 199.0%; Δ -60.40% < -1%) |
| CFO/TA 0.12 > 3% & CFO 177.9m > Net Income 212.0m |
| Net Debt (-554.8m) to EBITDA (221.9m): -2.50 < 3 |
| Current Ratio: 8.86 > 1.5 & < 3 |
| Outstanding Shares: last quarter (185.5m) vs 12m ago 11.40% < -2% |
| Gross Margin: 66.76% > 18% (prev 0.63%; Δ 6613 % > 0.5%) |
| Asset Turnover: 76.26% > 50% (prev 38.46%; Δ 37.80% > 0%) |
| Interest Coverage Ratio: -30.47 > 6 (EBITDA TTM 221.9m / Interest Expense TTM -6.87m) |
Altman Z'' 6.88
| A: 0.76 (Total Current Assets 1.24b - Total Current Liabilities 140.4m) / Total Assets 1.45b |
| B: 0.04 (Retained Earnings 62.9m / Total Assets 1.45b) |
| C: 0.20 (EBIT TTM 209.2m / Avg Total Assets 1.04b) |
| D: 0.38 (Book Value of Equity 62.2m / Total Liabilities 163.2m) |
| Altman-Z'' Score: 6.88 = AAA |
Beneish M -0.63
| DSRI: 0.74 (Receivables 245.2m/101.8m, Revenue 796.1m/245.6m) |
| GMI: 0.95 (GM 66.76% / 63.24%) |
| AQI: 2.72 (AQ_t 0.07 / AQ_t-1 0.03) |
| SGI: 3.24 (Revenue 796.1m / 245.6m) |
| TATA: 0.02 (NI 212.0m - CFO 177.9m) / TA 1.45b) |
| Beneish M-Score: -0.63 (Cap -4..+1) = D |
What is the price of CRDO shares?
Over the past week, the price has changed by -11.08%, over one month by -16.21%, over three months by -31.55% and over the past year by +39.88%.
Is CRDO a buy, sell or hold?
- StrongBuy: 9
- Buy: 3
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the CRDO price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 211.5 | 89.9% |
| Analysts Target Price | 211.5 | 89.9% |
| ValueRay Target Price | 162.3 | 45.7% |
CRDO Fundamental Data Overview February 02, 2026
P/E Forward = 36.3636
P/S = 28.4245
P/B = 18.1843
Revenue TTM = 796.1m USD
EBIT TTM = 209.2m USD
EBITDA TTM = 221.9m USD
Long Term Debt = 16.4m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 3.34m USD (from shortTermDebt, last fiscal year)
Debt = 12.8m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -554.8m USD (from netDebt column, last quarter)
Enterprise Value = 21.83b USD (22.63b + Debt 12.8m - CCE 813.6m)
Interest Coverage Ratio = -30.47 (Ebit TTM 209.2m / Interest Expense TTM -6.87m)
EV/FCF = 152.0x (Enterprise Value 21.83b / FCF TTM 143.6m)
FCF Yield = 0.66% (FCF TTM 143.6m / Enterprise Value 21.83b)
FCF Margin = 18.04% (FCF TTM 143.6m / Revenue TTM 796.1m)
Net Margin = 26.63% (Net Income TTM 212.0m / Revenue TTM 796.1m)
Gross Margin = 66.76% ((Revenue TTM 796.1m - Cost of Revenue TTM 264.6m) / Revenue TTM)
Gross Margin QoQ = 67.55% (prev 67.41%)
Tobins Q-Ratio = 15.06 (Enterprise Value 21.83b / Total Assets 1.45b)
Interest Expense / Debt = 13.29% (Interest Expense 1.70m / Debt 12.8m)
Taxrate = 1.25% (1.05m / 83.7m)
NOPAT = 206.6m (EBIT 209.2m * (1 - 1.25%))
Current Ratio = 8.86 (Total Current Assets 1.24b / Total Current Liabilities 140.4m)
Debt / Equity = 0.01 (Debt 12.8m / totalStockholderEquity, last quarter 1.29b)
Debt / EBITDA = -2.50 (Net Debt -554.8m / EBITDA 221.9m)
Debt / FCF = -3.86 (Net Debt -554.8m / FCF TTM 143.6m)
Total Stockholder Equity = 841.8m (last 4 quarters mean from totalStockholderEquity)
RoA = 20.31% (Net Income 212.0m / Total Assets 1.45b)
RoE = 25.18% (Net Income TTM 212.0m / Total Stockholder Equity 841.8m)
RoCE = 24.38% (EBIT 209.2m / Capital Employed (Equity 841.8m + L.T.Debt 16.4m))
RoIC = 24.54% (NOPAT 206.6m / Invested Capital 841.8m)
WACC = 15.65% (E(22.63b)/V(22.64b) * Re(15.65%) + D(12.8m)/V(22.64b) * Rd(13.29%) * (1-Tc(0.01)))
Discount Rate = 15.65% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 11.11%
[DCF Debug] Terminal Value 44.08% ; FCFF base≈143.6m ; Y1≈94.3m ; Y5≈43.0m
Fair Price DCF = 5.18 (EV 380.7m - Net Debt -554.8m = Equity 935.5m / Shares 180.6m; r=15.65% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: 76.36 | EPS CAGR: 128.9% | SUE: 3.17 | # QB: 5
Revenue Correlation: 87.31 | Revenue CAGR: 76.55% | SUE: 2.97 | # QB: 5
EPS current Year (2026-04-30): EPS=2.79 | Chg30d=+0.013 | Revisions Net=+2 | Growth EPS=+299.0% | Growth Revenue=+173.4%
EPS next Year (2027-04-30): EPS=3.80 | Chg30d=+0.075 | Revisions Net=+2 | Growth EPS=+36.1% | Growth Revenue=+40.7%